MedTrace Logo

Early Diagnosis of Pulmonary Hypertension in Patients With Inflammatory Rheumatic Connective Tissue Diseases

NCT01387035 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2022-07-14

No results posted yet for this study

Summary

The purposes of this study are (I), to evaluate various screening methods for their ability to predict and to confirm Pulmonary Hypertension (PH) in scleroderma patients, and (II) to evaluate the incidence of PH (i.e. the number of new cases per year) in scleroderma patients.

Conditions

  • Connective Tissue Disease
  • Pulmonary Hypertension

Sponsors & Collaborators

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Christian Nagel, MD · Center for pulmonary hypertension, Thoraxclinic Heidelberg

  • Ekkehard Grünig, Professor · Center for pulmonary hypertension, Thoraxclinic Heidelberg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01387035 on ClinicalTrials.gov